References
- Akiibinu, M.O., Ogunyemi, E.O., and Shoyebo, E.O., 2011. Levels of oxidative metabolites, antioxidants and neopterin in Nigerian pulmonary tuberculosis patients. European journal of general medicine, 8, 213–218.
- Alli, J.A., et al., 2014. Oxidative stress and reduced vitamins C and E levels are associated with multi-drug resistant tuberculosis. Journal of tuberculosis research, 2, 52–58.
- Berdowska, A. and Zwirska-Korczala, K., 2001. Neopterin measurement in clinical diagnosis. Journal of clinical pharmacy and therapeutics, 26, 319–329.
- Dalle-Donne, I., et al., 2003. Protein carbonyl groups as biomarkers of oxidative stress. Clinica chimica acta, 329, 23–38.
- Dalvi, S.M., 2012. Carbonyl protein and antioxidant vitamins in pulmonary and extra pulmonary tuberculosis. Journal of physiology and pharmacology advances, 2, 210–215.
- Dalvi, S.M., Patil, V.W., and Ramraje, N.N., 2012. The roles of glutathione, glutathioneperoxidase, glutathione reductase and the carbonyl protein in pulmonary and extrapulmonary tuberculosis. Journal of clinical and diagnostic research, 6, 1462–1465.
- Darbur, R.S., et al., 2010. Immunological correlation of oxidative stress markers in tuberculosis patients. International journal of biological and medical research, 1, 185–187.
- Hosp, M., et al., 1997. Neopterin, beta 2-microglobulin, and acute phase proteins in HIV-1-seropositive and -seronegative Zambian patients with tuberculosis. Lung, 175, 265–275.
- Immanuel, C., et al., 2001. Serial evaluation of serum neopterin in HIV seronegative patients treated for tuberculosis. International journal of tuberculosis and lung disease, 5, 185–190.
- Kulkarni, A. and Madrasi, N.A., 2008. Relationship of nitric oxide and protein carbonyl in tuberculosis. Indian journal of tuberculosis, 55, 138–144.
- Kulkarni, R., Deshpande, A., and Saxena, R., 2013. A study of serum malondialdehyde and cytokine in tuberculosis patients. Journal of clinical and diagnostic research, 7, 2140–2142.
- Kwiatkowska, S., et al., 1999. Increased serum concentrations of conjugated dienes and malondialdehyde in patients with pulmonary tuberculosis. Respiratory medicine, 93, 272–276.
- Lamsal, M., et al., 2007. Evaluation of lipid peroxidation product, nitrite and antioxidant levels in newly diagnosed and two months follow-up patients with pulmonary tuberculosis. Southeast asian journal of tropical medicine and public health, 38, 695–703.
- Norbis, L., et al., 2014. Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis. Expert review of anti-infective therapy, 12, 633–647.
- Reddy, Y.N., et al., 2004. Role of free radicals and antioxidants in tuberculosis patients. Indian journal of tuberculosis, 51, 213–218.
- Tozkoparan, E., et al., 2005. The diagnostic values of serum, pleural fluid and urine neopterin measurements in tuberculous pleurisy. International journal of tuberculosis and lung disease, 9, 1040–1045.
- Turgut, T., et al., 2006. Serum interleukin-2 and neopterin levels as useful markers for treatment of active pulmonary tuberculosis. Tohoku journal of experimental medicine, 209, 321–328.
- Wallis, R.S., et al., 2009. Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet infectious diseases, 9, 162–172.
- World Health Organization, 2008. Joint TDR/EC expert consultation on biomarkers in tuberculosis: Report of the joint TDR/EC expert consultation to evaluate the potential roles of biomarkers in the management of HIV-infected and HIV-uninfected patients with tuberculosis. Geneva: World Health Organization. Available from: http://www.who.int/tdr/publications/documents/biomarkers.pdf.